138 related articles for article (PubMed ID: 11042658)
21. Analysis of cytomegalovirus (CMV) viremia using the pp65 antigenemia assay, the amplicor CMV test, and a semi-quantitative polymerase chain reaction test after allogeneic marrow transplantation.
Ksouri H; Eljed H; Greco A; Lakhal A; Torjman L; Abdelkefi A; Ben Othmen T; Ladeb S; Slim A; Zouari B; Abdeladhim A; Ben Hassen A
Transpl Infect Dis; 2007 Mar; 9(1):16-21. PubMed ID: 17313466
[TBL] [Abstract][Full Text] [Related]
22. Cytomegalovirus prophylaxis and treatment after hematopoietic stem cell transplantation in Canada: a description of current practices and comparison with Centers for Disease Control/Infectious Diseases Society of America/American Society for Blood and Marrow Transplantation guideline recommendations.
Fraser GA; Walker II;
Biol Blood Marrow Transplant; 2004 May; 10(5):287-97. PubMed ID: 15111928
[TBL] [Abstract][Full Text] [Related]
23. Monitoring of cytomegalovirus reactivation after allogeneic stem cell transplantation: comparison of an antigenemia assay and quantitative real-time polymerase chain reaction.
Yakushiji K; Gondo H; Kamezaki K; Shigematsu K; Hayashi S; Kuroiwa M; Taniguchi S; Ohno Y; Takase K; Numata A; Aoki K; Kato K; Nagafuji K; Shimoda K; Okamura T; Kinukawa N; Kasuga N; Sata M; Harada M
Bone Marrow Transplant; 2002 Apr; 29(7):599-606. PubMed ID: 11979310
[TBL] [Abstract][Full Text] [Related]
24. Cytomegalovirus as a cause of very late interstitial pneumonia after bone marrow transplantation.
de Medeiros CR; Moreira VA; Pasquini R
Bone Marrow Transplant; 2000 Aug; 26(4):443-4. PubMed ID: 10982292
[TBL] [Abstract][Full Text] [Related]
25. Effective pre-emptive therapy with Ganciclovir and specific immunoglobulins for CMV infection in a bone marrow transplanted patient.
Dentamaro T; Volpi A; Cudillo L; Masi M; Tribalto M; Sordillo P; Salanitro A; Papa G
Haematologica; 1992; 77(3):284-6. PubMed ID: 1330849
[TBL] [Abstract][Full Text] [Related]
26. Clinical strategies for the management of cytomegalovirus infection and disease in allogeneic bone marrow transplant.
Prentice HG; Kho P
Bone Marrow Transplant; 1997 Jan; 19(2):135-42. PubMed ID: 9116610
[TBL] [Abstract][Full Text] [Related]
27. CMV prophylaxis in allogeneic BMT with ganciclovir and CMV immune globulin.
Patton WN; Carter C; Bienz N; Lamb T; Boughton BJ; Franklin IM
Bone Marrow Transplant; 1991; 7 Suppl 2():44. PubMed ID: 1652330
[No Abstract] [Full Text] [Related]
28. High-dose acyclovir and pre-emptive ganciclovir in prevention of cytomegalovirus disease in pediatric patients following peripheral blood stem cell transplantation.
Hazar V; Kansoy S; Küpesiz A; Aksoylar S; Kantar M; Yeşilipek A
Bone Marrow Transplant; 2004 May; 33(9):931-5. PubMed ID: 15034541
[TBL] [Abstract][Full Text] [Related]
29. Cytomegalovirus infection in the bone marrow transplant recipient.
Zaia JA; Forman SJ
Infect Dis Clin North Am; 1995 Dec; 9(4):879-900. PubMed ID: 8747771
[TBL] [Abstract][Full Text] [Related]
30. Ganciclovir and the prevention of CMV disease after allogeneic BMT: policy at the Hammersmith Hospital.
Ward KN; Roberts IA; van Rhee F
Bone Marrow Transplant; 1994 Feb; 13(2):230-1. PubMed ID: 8205098
[No Abstract] [Full Text] [Related]
31. Cytomegalovirus antigenemia and outcomes of patients undergoing allogeneic peripheral blood stem cell transplantation: effects of long-term high-dose acyclovir prophylaxis and preemptive ganciclovir treatment.
Hazar V; Ugur A; Colak D; Saba R; Tezcan G; Kupesiz A; Karadogan I; Gultekin M; Yesilipek A; Undar L
Jpn J Infect Dis; 2006 Aug; 59(4):216-21. PubMed ID: 16936338
[TBL] [Abstract][Full Text] [Related]
32. Cytomegalovirus viral load monitoring after allogeneic bone marrow transplantation in patients receiving antiviral prophylaxis.
Howden BP; Michaelides A; Spelman DW; Spencer A; Schwarer AP; Wesselingh S; Kotsimbos TC
Bone Marrow Transplant; 2003 Oct; 32(8):795-800. PubMed ID: 14520424
[TBL] [Abstract][Full Text] [Related]
33. A prospective study comparing cytomegalovirus antigenemia, DNAemia and RNAemia tests in guiding pre-emptive therapy in thoracic organ transplant recipients.
Lehto JT; Lemström K; Halme M; Lappalainen M; Lommi J; Sipponen J; Harjula A; Tukiainen P; Koskinen PK
Transpl Int; 2005 Dec; 18(12):1318-27. PubMed ID: 16297050
[TBL] [Abstract][Full Text] [Related]
34. CMV monitoring after peripheral blood stem cell and bone marrow transplantation by pp65 antigen and quantitative PCR.
Schulenburg A; Watkins-Riedel T; Greinix HT; Rabitsch W; Loidolt H; Keil F; Mitterbauer M; Kalhs P
Bone Marrow Transplant; 2001 Oct; 28(8):765-8. PubMed ID: 11781628
[TBL] [Abstract][Full Text] [Related]
35. Low-dose short-course intravenous ganciclovir as pre-emptive therapy for CMV viremia post allo-PBSC transplantation.
Vij R; Khoury H; Brown R; Goodnough LT; Devine SM; Blum W; Adkins D; DiPersio JF
Bone Marrow Transplant; 2003 Oct; 32(7):703-7. PubMed ID: 13130318
[TBL] [Abstract][Full Text] [Related]
36. [Effectiveness of preemptive therapy with ganciclovir in recipients of renal transplants at high risk (R-/D+) for the development of cytomegalovirus disease].
Aranda-Verástegui F; Alberú J; Soto-Ramírez LE; González-Aguirre H; Muñoz Trejo T; Mancilla E; Díliz H; Correa-Rotter R; Sierra-Madero J
Rev Invest Clin; 2002; 54(3):198-203. PubMed ID: 12183888
[TBL] [Abstract][Full Text] [Related]
37. Immune globulin therapy in allogeneic bone marrow transplant: a critical review.
Guglielmo BJ; Wong-Beringer A; Linker CA
Bone Marrow Transplant; 1994 May; 13(5):499-510. PubMed ID: 8054903
[TBL] [Abstract][Full Text] [Related]
38. Management of CMV infection and disease in transplant patients. 27-29 February 2004.
Razonable RR; Emery VC;
Herpes; 2004 Dec; 11(3):77-86. PubMed ID: 15960905
[TBL] [Abstract][Full Text] [Related]
39. High frequency of positive surveillance for cytomegalovirus (CMV) by PCR in allograft recipients at low risk of CMV.
Butt NM; Clark RE
Bone Marrow Transplant; 2001 Mar; 27(6):615-9. PubMed ID: 11319591
[TBL] [Abstract][Full Text] [Related]
40. Progress in the prevention of cytomegalovirus infection after allogeneic bone marrow transplantation.
Devergie A; Traineau R; Esperou-Bourdeau H; Ribaud P; Socié G; Richard P; Selimi F; Hirsch I; Gluckman E
Nouv Rev Fr Hematol (1978); 1994; 36 Suppl 1():S89-90. PubMed ID: 8177726
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
